Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in pediatric chronic ITP (PETIT2)
NCT01520909Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Started Mar 2012; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01520909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01520909.